Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sujuan Sun

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Diabetes, Obesity & Metabolism|August 1, 2019
A novel specific peroxisome proliferator-activated receptor γ (PPARγ) modulator YR4-42 ameliorates hyperglycaemia and dyslipidaemia and hepatic steatosis in diet-induced obese miceYi Huan, Xuan Pan, Jun Peng, et al.
Scientific Reports|June 30, 2017
The dual DPP4 inhibitor and GPR119 agonist HBK001 regulates glycemic control and beta cell function ex and in vivoYi Huan, Qian Jiang, Gang Li, et al.
Fluids and Barriers of the CNS|April 17, 2024
Choroid plexus enlargement in amyotrophic lateral sclerosis patients and its correlation with clinical disability and blood-CSF barrier permeabilityTingjun Dai, Jianwei Lou, Deyuan Kong, et al.
Biochemical Pharmacology|January 23, 2018
Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R antibody fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sitesCaina Li, Miaomiao Yang, Xiaofeng Wang, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Diabetes, Obesity & Metabolism|August 1, 2019
A novel specific peroxisome proliferator-activated receptor γ (PPARγ) modulator YR4-42 ameliorates hyperglycaemia and dyslipidaemia and hepatic steatosis in diet-induced obese miceYi Huan, Xuan Pan, Jun Peng, et al.
Scientific Reports|June 30, 2017
The dual DPP4 inhibitor and GPR119 agonist HBK001 regulates glycemic control and beta cell function ex and in vivoYi Huan, Qian Jiang, Gang Li, et al.
Fluids and Barriers of the CNS|April 17, 2024
Choroid plexus enlargement in amyotrophic lateral sclerosis patients and its correlation with clinical disability and blood-CSF barrier permeabilityTingjun Dai, Jianwei Lou, Deyuan Kong, et al.
Biochemical Pharmacology|January 23, 2018
Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R antibody fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sitesCaina Li, Miaomiao Yang, Xiaofeng Wang, et al.
Pageof 7